E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/10/2006 in the Prospect News Biotech Daily.

New Issue: Thermage raises $42 million in IPO of 6 million shares at $7 each - below reduced guidance

By Ronda Fears

Memphis, Nov. 10 - Thermage, Inc. raised $42 million from its initial public offering of 6 million shares at $7 each - below lowered price talk of $8 to $9 per share, which was cut from $11 to $13 - via lead manager Merrill Lynch & Co.

Hayward, Calif.-based Thermage has developed ThermaCool, a non-invasive treatment of wrinkles approved for commercial sales. Proceeds are slated for marketing, research and to repay its working capital line of credit.

Issuer:Thermage, Inc.
Issue:Initial public offering
Gross proceeds:$42 million
Shares:6 million
Greenshoe:900,000 shares
Price:$7 per share
Price talk:Revised: $8 to $9 per share
Original: $11 to $13 per share
Bookrunner:Merrill Lynch & Co.
Co-managers:Thomas Weisel Partners LLC, Wachovia Securities, C. E. Unterberg, Towbin and Maxim Group LLC
Pricing date:Nov. 9
Settlement date:Nov. 15
Stock symbol:Nasdaq: THRM

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.